Jacob Thaysen was named to the role after Francis deSouza resigned from the gene-sequencing maker in June amid a fight with regulators.
Source link
Tags: Biotechnology Services, C&E Executive News Filter, C&E Industry News Filter, Content Types, corporate, Corporate Governance, Corporate/Industrial News, environmental, Environmental/Social/Governance, Factiva Filters, Genomics, governance, government policy, healthcare, Healthcare/Life Sciences, Illumina, ILMN, industrial news, Jacob Thaysen, life sciences, Management, Management Moves, medical equipment, Medical Equipment/Supplies, Proxy Fight, regulation, Regulation/Government Policy, Senior Level Management, Shareholder Activism, social, supplies, SYND, WSJ-PRO-WSJ.com, wsjhealth
